Sonokine Biosciences
Launched:
2022
Management:
Herbert Kim Lyerly
Duke Inventor(s):
Herbert Kim Lyerly, Zach Hartman, Takuya Osada
Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies.